Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum

American Journal of Psychiatry

Volumn 163, Issue 12, 2006, Pages 2064-2070

  Yaeger, Deborah ^a   Smith, Healy G ^b   Altshuler, Lori L ^b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; TIOTIXENE;

ADULT; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; FEMALE; HUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SCHIZOPHRENIA;

EID: 33846308483     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.12.2064     Document Type: Article

References (39)

1. Leung A, Chue P: Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000; 401:3-38
2. Castle DJ: Women and schizophrenia: an epidemiological perspective, in Women and Schizophrenia. Edited by Castle DJ, McGrath J, Kulkarni T. Cambridge, Mass, Cambridge University Press, 2000, pp 19-33
3. Seeman MV: The role of sex hormones in psychopathology: focus on schizophrenia. Prim Care 2002; 29:viii, 171-182
4. Seeman MV: Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004; 161:1324-1333
5. Howard LM, Kumar R, Thornicroft G: Psychosocial characteristics and needs of mothers with psychotic disorders. Br J Psychiatry 2001; 178:427-432
6. Howard LM: Fertility and pregnancy in women with psychotic disorders. Eur J Obstet Gynecol Reprod Biol 2005; 119:3-10
7. Miller LJ: Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 1997; 23:623-635
8. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J: Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153:592-606
9. Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM: Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 2002; 58:221-229
10. O'Connor TG, Ben Shlomo Y, Heron J, Golding J, Adams D, Glover V: Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005; 58:211-217
11. Hansen D, Lou HC, Olsen J: Serious life events and congenital malformations: a national study with complete follow-up. Lancet 2000; 356: 875-880
12. Field T, Diego M, Hernandez-Reif M, Schanberg S, Kuhn C, Yando R, Bendell D: Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate: Depress Anxiety 2003; 17:140-151
13. Dunkel-Schetter C, Wadhwa P, Stanton AL: Stress and reproduction: introduction to the special section. Health Psychol 2000; 19:507-509
14. Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A: Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 2005; 66:317-322
15. Cohen LS, Rosenbaum JF: Psychotropic drug use during pregnancy: weighing the risks. J Clin Psychiatry 1998; 59(suppl 2):18-28
16. Kohen D: Psychotropic medication in pregnancy. Advances in Psychiatr Treatment 2004; 10:59-66
17. Kris EB: Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr Ther Res Clin Exp 1965; 7:785-789
18. Stika L, Elisova K, Honzakova L, Hrochova H, Plechatova H, Strnadova J, Stop B, Svihovec J, Vachova M, Vinar O: Effects of drug administration in pregnancy on children's school behaviour. Pharm Weekbl Sci 1990; 12:252-255
19. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, DiavCitrin O, Levinson A, Zipursky RB, Einarson A: Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66:444-449
20. Brost BC, Goldenberg RL, Mercer BM, Iams JD, Meis PJ, Moawad AH, Newman RB, Miodovnik M, Caritis SN, Thurnau GR, Bottoms SF, Das A, McNellis D: The preterm prediction study: association of cesarean delivery with increases in maternal weight and body mass index. Am J Obstet Gynecol 1997; 177:333-337
21. Lu GC, Rouse DJ, DuBard M, Cliver S, Kimberlin D, Hauth JC: The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001; 185:845-849
22. Boney CM, Verma A, Tucker R, Vohr BR: Metabolic syndrome in childhood: associations with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115:290-296
23. Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ: Pre-pregnancy weight and the risk of stillbirth and neonatal death. Br J Obstet Gynaecol 2005; 112:403-408
24. Anderson JL, Waller DK, Canfield MA, Shaw GM, Watkins ML, Werler MM: Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology 2005; 16:87-92
25. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A: A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology 2000; 11:689-694
26. Ricart W, Lopez J, Mozas J, Pericot A, Sancho MA, Gonzalez N, Balsells M, Luna R, Cortazar A, Navarro P, Ramirez O, Flandez B, Pallardo LF, Hernandez-Mijas A, Ampudia J, Fernandez-Real JM, Corcoy R: Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 2005; 48:1736-1742
27. Ray JG, Burrows RF, Burrows EA, Vermeulen MJ: Medical Outcomes Study hypertension in pregnancy: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 2001; 64:129-143
28. Bagedahl-Strindlund M: Parapartum mental illness: timing of illness onset and its relation to symptoms and sociodemographic characteristics. Acta Psychiatr Scand 1986; 74:490-496
29. McNeil TF: A prospective study of postpartum psychoses in a high-risk group, 1: clinical characteristics of the current postpartum episodes. Acta Psychiatr Scand 1986; 74:205-216
30. Schopf J, Bryois C, Jonquiere M, Le PK: On the nosology of severe psychiatric post-partum disorders: results of a catamnestic investigation. Eur Arch Psychiatr Neurol Sci 1984; 234:54-63
31. Snellen M, Mack K, Trauer T: Schizophrenia, mental state, and mother-infant interaction: examining the relationship. Aust NZ J Psychiatry 1999; 33:902-911
32. Gamer E, Gallant D, Grunebaum H: Children of psychotic mothers: an evaluation of 1-year-olds on a test of object permanence. Arch Gen Psychiatry 1976; 33:311-317
33. Spinelli MG: Maternal infanticide associated with mental illness: prevention and the promise of saved lives. Am J Psychiatry 2004; 161:1548-1557
34. Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF, Kohan R, Rampono J: Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003; 160:1428-1431
35. Hill RC, Mclvor RJ, Wojnar-Horton RE, Hackett LP, Ilett KF: Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 2000; 20:285-286
36. Aichhorn W, Stuppaeck C, Whitworth AB: Risperidone and breast-feeding. J Psychopharmacol 2005; 19:211-213
37. Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg EJ: Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 2004; 38:273-276
38. Lee A, Giesbrecht E, Dunn E, Ito S: Excretion of quetiapine in breast milk. Am J Psychiatry 2004; 161:1715-1716
39. Dev V, Krupp P: Adverse event profile and safety of clozapine. Rev Contemp Pharmacother 1995; 6:197-208